ELITE PHARMACEUTICALS's ticker is ELTP and the CUSIP is 28659T200. A total of 5 filers reported holding ELITE PHARMACEUTICALS in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $10,284,000 | +289.5% | 120,000 | +100.0% | 0.00% | – |
Q2 2019 | $2,640,000 | -55.6% | 60,000 | 0.0% | 0.00% | -100.0% |
Q1 2019 | $5,940,000 | -33.9% | 60,000 | -50.0% | 0.00% | 0.0% |
Q4 2018 | $8,988,000 | +66.4% | 120,000 | +100.0% | 0.00% | 0.0% |
Q3 2018 | $5,400,000 | 0.0% | 60,000 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $5,400,000 | -10.0% | 60,000 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $6,000,000 | +8.7% | 60,000 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $5,520,000 | -8.9% | 60,000 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $6,060,000 | -46.3% | 60,000 | 0.0% | 0.00% | -50.0% |
Q2 2017 | $11,280,000 | +27.1% | 60,000 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $8,874,000 | -2.7% | 60,000 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $9,120,000 | -13.6% | 60,000 | 0.0% | 0.00% | -33.3% |
Q3 2016 | $10,560,000 | -45.8% | 60,000 | 0.0% | 0.00% | -40.0% |
Q2 2016 | $19,500,000 | +4.8% | 60,000 | 0.0% | 0.01% | 0.0% |
Q1 2016 | $18,600,000 | -24.2% | 60,000 | 0.0% | 0.01% | -16.7% |
Q4 2015 | $24,540,000 | +77.8% | 60,000 | 0.0% | 0.01% | +100.0% |
Q3 2015 | $13,800,000 | +15.0% | 60,000 | 0.0% | 0.00% | +50.0% |
Q2 2015 | $12,000,000 | -18.4% | 60,000 | 0.0% | 0.00% | -33.3% |
Q1 2015 | $14,700,000 | +8.4% | 60,000 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $13,560,000 | -29.6% | 60,000 | 0.0% | 0.00% | -25.0% |
Q3 2014 | $19,272,000 | -24.4% | 60,000 | 0.0% | 0.00% | -20.0% |
Q2 2014 | $25,500,000 | +3.8% | 60,000 | 0.0% | 0.01% | 0.0% |
Q1 2014 | $24,570,000 | +241.2% | 60,000 | 0.0% | 0.01% | +150.0% |
Q4 2013 | $7,200,000 | -3.1% | 60,000 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $7,434,000 | +72.1% | 60,000 | 0.0% | 0.00% | +100.0% |
Q2 2013 | $4,320,000 | – | 60,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FISHMAN JAY A LTD/MI | 60,000 | $8,874,000 | 0.00% |
Sargent Bickham Lagudis LLC | 40,000 | $6,000 | 0.00% |
Geneva Advisors, LLC | 353,060 | $52,000 | 0.00% |